BDBM631151 (4R)-1-[2-[2-[2-[2-[[2-[(9S)-7-(4-Chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2::US11802131, Example C

SMILES Cc1sc-2c(c1C)C(=N[C@@H](CC(=O)NCCOCCOCCOCC(=O)N1CC[C@@H](C(=O)N[C@H]3CCC(=O)NC3=O)c3ccccc13)c1nnc(C)n-21)c1ccc(Cl)cc1

InChI Key InChIKey=OYPYVJUTCQQGQG-UHFFFAOYSA-N

Data  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 631151   

TargetDNA damage-binding protein 1/Protein cereblon(Human)
C4 Therapeutics

US Patent
LigandPNGBDBM631151(US11802131, Example C | (4R)-1-[2-[2-[2-[2-[[2-[(9...)
Affinity DataKd:  8nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2023
Entry Details
Go to US Patent